Both in Biotechnology
TScan Therapeutics vs Passage Bio
Over the past year TCRX returned −91.0% and PASG returned −51.7%; their daily moves had a correlation of 0.07.
TCRX −91.0% PASG −51.7%Growth of $1, one year, split-adjusted
| Metric | TCRX | PASG |
|---|---|---|
| Price | $0.1923 | $3.70 |
| Market cap | $13.0M | $11.9M |
| Today | −3.32% | +11.11% |
| 1 month | −38.9% | −17.8% |
| 6 months | −83.4% | −27.6% |
| Year to date | −80.8% | −68.6% |
| 1 year | −91.0% | −51.7% |
| Revenue growth (YoY) | −65.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −2888.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | — |
| Net cash | $67.4M | $24.2M |
| Dividend yield | — | — |
| Volatility (60d) | 139.1% | 79.7% |
| Short % of float | 4.1% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).